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Abstract
Background: DNA methylation is an important epigenetic mechanism involved in gene regulation, with alterations
in DNA methylation in the nuclear genome being linked to numerous complex diseases. Mitochondrial DNA
methylation is a phenomenon that is receiving ever-increasing interest, particularly in diseases characterized by
mitochondrial dysfunction; however, most studies have been limited to the investigation of specific target regions.
Analyses spanning the entire mitochondrial genome have been limited, potentially due to the amount of input
DNA required. Further, mitochondrial genetic studies have been previously confounded by nuclear-mitochondrial
pseudogenes. Methylated DNA Immunoprecipitation Sequencing is a technique widely used to profile DNA
methylation across the nuclear genome; however, reads mapped to mitochondrial DNA are often discarded. Here,
we have developed an approach to control for nuclear-mitochondrial pseudogenes within Methylated DNA
Immunoprecipitation Sequencing data. We highlight the utility of this approach in identifying differences in
mitochondrial DNA methylation across regions of the human brain and pre-mortem blood.
Results: We were able to correlate mitochondrial DNA methylation patterns between the cortex, cerebellum and
blood. We identified 74 nominally significant differentially methylated regions (p < 0.05) in the mitochondrial
genome, between anatomically separate cortical regions and the cerebellum in matched samples (N = 3 matched
donors). Further analysis identified eight significant differentially methylated regions between the total cortex and
cerebellum after correcting for multiple testing. Using unsupervised hierarchical clustering analysis of the
mitochondrial DNA methylome, we were able to identify tissue-specific patterns of mitochondrial DNA methylation
between blood, cerebellum and cortex.
Conclusions: Our study represents a comprehensive analysis of the mitochondrial methylome using pre-existing
Methylated DNA Immunoprecipitation Sequencing data to identify brain region-specific patterns of mitochondrial
DNA methylation.
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Introduction
Mitochondria are unique organelles in that they have their
own circular genome, approximately 16.6 kb in size [1].
Mitochondrial DNA (mtDNA) consists of 37 genes, 22 en-
coding for transfer RNAs (tRNAs), two for ribosomal
RNAs (rRNAs) and 13 encoding for proteins important in
the electron transport chain. Each of these 13 proteins are
directly involved in the regulation of cellular respiration,
generating the majority of ATP required for the process.
However, mitochondria have an array of other important
cellular roles such as calcium homeostasis [2] and neural
stem cell differentiation [3]. As such, abnormal mitochon-
drial function, dynamics and trafficking have been ass-
ociated with a number of brain disorders including
Alzheimer’s disease [4, 5], schizophrenia [6], bipolar dis-
order [7] and major depressive disorder [8].
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Epigenetic processes mediate the reversible regulation
of gene expression, occurring independently of DNA se-
quence variation, acting principally through chemical
modifications to DNA and nucleosomal histone proteins
and orchestrate a diverse range of important physio-
logical functions. DNA methylation is the best character-
ized and most stable epigenetic modification modulating
the transcription of mammalian genomes and, because it
can be robustly assessed using existing genomic DNA
resources, is the focus of most human epidemiological
epigenetic research to date [9]. The most widely used
method for epigenome-wide analysis of DNA methyla-
tion is the Illumina 450K methylation array, and a num-
ber of studies have recently shown differential DNA
methylation of the nuclear genome (ncDNA), between
different tissue types [10–12] and also in a range of com-
plex diseases, from brain disorders such as Alzheimer’s
disease [13–15] and schizophrenia [16, 17], to systemic
diseases such as type 2 diabetes [18] and Crohn’s disease
[19]. However, with no representation of the mitochon-
drial genome on this platform, as well as a lack of analysis
on other genome-wide platforms, the role of mtDNA
methylation has been largely neglected [20, 21].
Since the identification of 5-methylcytosine (5-mC) in
mitochondria, research into mtDNA methylation as an
independent and potentially relevant mark has received
more regular attention [22, 23]. However, most research
is either focussed on low resolution, global DNA methy-
lation, or candidate gene DNA methylation changes
using techniques such as bisulfite pyrosequencing [20].
These recent publications have indicated that differences
in mtDNA methylation are present in a variety of differ-
ent phenotypes [24–29] and may have potential utility as
a biomarker [30]. In addition, a recent study has
explored the use of Methylated DNA Immunoprecipita-
tion Sequencing (MeDIP-seq) to investigate changes in
mtDNA methylation across 39 cell lines and tissues from
publicly available data [31]. At present, genome-wide se-
quencing technologies have not yet been used to interro-
gate alterations in the mtDNA methylome across tissues
in the same individuals.
A high proportion of current, publicly available, genome-
wide DNA methylation data has been generated through
the use of MeDIP-seq, a method designed to interrogate
genome-wide changes in methylation at high throughput
and low cost [32]. However, given the presence of nuclear-
mitochondrial pseudogenes (NUMTs), regions of the nu-
clear genome that share a high sequence homology with
their mitochondrial paralogue [33, 34], mitochondrial reads
are often discarded from further analysis. The development
of bioinformatic pipelines to investigate regions of differen-
tial mtDNA methylation from whole genome data would
provide a novel way in which to interrogate the mtDNA
methylome in publicly available data. Here, we control for
the presence of NUMTs in a previously published MeDIP-
seq dataset, to investigate differential DNA methylation
across the mitochondrial genome in human post-mortem
brain samples.
Results
MtDNA methylation patterns are correlated between the
cortex, cerebellum and blood
To date, no study has investigated differences in mtDNA
methylation across different matched regions of human
brain and blood samples. Our sample (Table 1) consisted of
MeDIP-seq data from three individuals, free of any neuro-
pathology and neuropsychiatric disease, for five different
regions of the cortex (Brodmann areas (BA) 8, 9 and 10, su-
perior temporal gyrus (STG) and entorhinal cortex (ECX)),
the cerebellum (CER) and pre-mortem blood [35]. Given
that MeDIP-seq data has been generated from standardly
extracted total genomic DNA and thus contains a mixture
of ncDNA and mtDNA [36], we initially controlled for
regions of high sequence homology between the two
genomes within our data by realigning mtDNA reads to a
series of custom reference genomes using an in-house
pipeline (see the Methods section) to specifically analyze
mtDNA methylation (Fig. 1). Briefly, after an initial align-
ment to the GRCH37 reference genome using BWA,
uniquely mapped reads were extracted and aligned to a
custom GRCH37 reference genome not containing the
mitochondrial sequence. Reads that did not map to this
custom genome were found to share less homology with
the nuclear genome and were taken forward and realigned
once more to the full reference genome. Initially, we were
interested to investigate whether changes in mtDNA across
the mitochondrial genome were highly correlated between
different tissue types. Using principal component analysis
(PCA), we found that mtDNA methylation patterns are
highly correlated between different cortical regions (r >
0.99, p < 2.2E−16), with a slightly weaker correlation be-
tween the cerebellum and cortex (r > 0.97, p < 2.2E−16)
(Fig. 2). Due to the small number of blood samples avail-
able, deriving a significance level for the correlations be-
tween the cerebellum and blood could not be made.
Table 1 Demographic information
Individual Age at
death (years)
Age at bloods
sampled (years)
Post-mortem
delay (hours)
Gender
1 82 79 43 Female
2 92 N/A 17 Female
3 78 78 10 Male
MeDIP-seq data was available from post-mortem brain samples obtained from
three individuals free of any neuropathology and neuropsychiatric disease.
Data was available for five different regions of the cortex (Brodmann areas
(BA) 8, 9 and 10, superior temporal gyrus (STG), entorhinal cortex (ECX), the
cerebellum (CER) and pre-mortem blood (BLD). MeDIP-seq data was available
for all individuals from cortical and cerebellar samples; however, blood MeDIP-
seq data was not available for individual 2. Data is freely available to download
from http://epigenetics.iop.kcl.ac.uk/brain
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Instead, in an attempt to explore the similarity between
matched blood and cerebellum samples, the direction of
differential methylation with respect to the cortex was used.
Here, we found that 93.1% of the windows analyzed in the
cerebellum and blood had the same direction of methyla-
tion difference with respect to the cortex, further suggesting
a strong correlation between the two tissue types.
Differentially methylated regions of the mitochondrial
genome can be identified between anatomically distinct
cortical regions and the cerebellum
Having identified correlated mtDNA methylation pat-
terns across different brain regions, we were interested
to investigate whether we could identify differentially
methylated regions (DMRs) in the mitochondrial gen-
ome between different regions of the cortex and cerebel-
lum. To identify such tissue-specific DMRs within the
mitochondrial genome, paired t tests were performed
across matched cortical and cerebellum samples at
100 bp windows across the mitochondrial genome (see
the Methods section). In total, we identified 74 nomin-
ally significant DMRs (p < 0.05) between the five individ-
ual cortical regions and the cerebellum (Table 2; Fig. 3).
Of these DMRs, seven (Table 2, bold face) were found to
be present across all prefrontal cortex areas (BA8, BA9,
BA10). Furthermore, the direction of methylation
Fig. 1 Overview of the analysis pipeline
Fig. 2 MtDNA methylation patterns are correlated between the cortex, cerebellum and blood. Samples were ordered based upon the
similarity of their principal components, RPKM values, with r calculated for the correlations between each tissue. BLD blood, BA8
Brodmann area 8, BA9 Brodmann area 9, BA10 Brodmann area 10, CER cerebellum, CTX cortex, ECX entorhinal cortex, STG superior
temporal gyrus
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Table 2 List of DMRs identified between five anatomically discreet cortical regions and cerebellum
Start
(bp)
Stop
(bp)
Gene(s) BA8 BA9 BA10 EC STG
p value Δ RPKM p value Δ RPKM p value Δ RPKM p value Δ RPKM p value Δ RPKM
1 100 D-Loop - - - - - - - - - -
101 200 D-Loop - - - - - - - - - -
201 300 D-Loop - - - - - - - - - -
301 400 D-Loop - - - - - - - - - -
401 500 D-Loop - - - - - - - - - -
501 600 MT-TF - - - - - - - - - -
601 700 MT-TF/MT-RNR1 - - - - - - - - - -
701 800 MT-RNR1 - - - - - - 3.21E−02 79156 - -
801 900 MT-RNR1 4.31E−02 94246 2.93E−02 −43592 - - - - 1.79E−02 95257
901 1000 MT-RNR1 ND ND ND ND ND ND ND ND ND ND
1001 1100 MT-RNR1 ND ND ND ND ND ND ND ND ND ND
1101 1200 MT-RNR1 ND ND ND ND ND ND ND ND ND ND
1201 1300 MT-RNR1 ND ND ND ND ND ND ND ND ND ND
1301 1400 MT-RNR1 ND ND ND ND ND ND ND ND ND ND
1401 1500 MT-RNR1 ND ND ND ND ND ND ND ND ND ND
1501 1600 MT-RNR1 ND ND ND ND ND ND ND ND ND ND
1601 1700 MT-RNR1/MT-
TV/MT-RNR2
ND ND ND ND ND ND ND ND ND ND
1701 1800 MT-RNR2 ND ND ND ND ND ND ND ND ND ND
1801 1900 MT-RNR2 ND ND ND ND ND ND ND ND ND ND
1901 2000 MT-RNR2 ND ND ND ND ND ND ND ND ND ND
2001 2100 MT-RNR2 ND ND ND ND ND ND ND ND ND ND
2101 2200 MT-RNR2 ND ND ND ND ND ND ND ND ND ND
2201 2300 MT-RNR2 ND ND ND ND ND ND ND ND ND ND
2301 2400 MT-RNR2 2.54E−02 −97351 3.20E−02 −29509 4.31E−02 −82048 - - - -
2401 2500 MT-RNR2 8.90E−03 70950 - - - - - - - -
2501 2600 MT-RNR2 3.30E−03 51937 - - - - - - - -
2601 2700 MT-RNR2 ND ND ND ND ND ND ND ND ND ND
2701 2800 MT-RNR2 ND ND ND ND ND ND ND ND ND ND
2801 2900 MT-RNR2 - - - - - - - - - -
2901 3000 MT-RNR2 - - - - - - - - - -
3001 3100 MT-RNR2 - - - - - - - - - -
3101 3200 MT-RNR2 ND ND ND ND ND ND ND ND ND ND
3201 3300 MT-RNR2/MT-TL - - - - - - 2.09E−02 242424 - -
3301 3400 MT-TL1/MT-ND1 - - - - - - - - - -
3401 3500 MT-ND1 - - 1.54E−02 864685 - - - - - -
3501 3600 MT-ND1 4.41E−02 1180914 - - 1.72E−02 226066 - - - -
3601 3700 MT-ND1 4.73E−02 1250436 4.52E−02 1228936 3.73E−02 1183681 - - - -
3701 3800 MT-ND1 - - - - 2.16E−02 20818 - - - -
3801 3900 MT-ND1 - - - - - - - - - -
3901 4000 MT-ND1 - - - - - - - - - -
4001 4100 MT-ND1 2.41E−02 −39498 1.55E−02 −38704 - - 4.68E−02 −49753 1.56E−02 243767
4101 4200 MT-ND1 ND ND ND ND ND ND ND ND ND ND
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Table 2 List of DMRs identified between five anatomically discreet cortical regions and cerebellum (Continued)
4201 4300 MT-ND1/MT-TI ND ND ND ND ND ND ND ND ND ND
4301 4400 MT-TI/MT-TQ ND ND ND ND ND ND ND ND ND ND
4401 4500 MT-TM/MT-ND2 ND ND ND ND ND ND ND ND ND ND
4501 4600 MT-ND2 ND ND ND ND ND ND ND ND ND ND
4601 4700 MT-ND2 ND ND ND ND ND ND ND ND ND ND
4701 4800 MT-ND2 ND ND ND ND ND ND ND ND ND ND
4801 4900 MT-ND2 ND ND ND ND ND ND ND ND ND ND
4901 5000 MT-ND2 ND ND ND ND ND ND ND ND ND ND
5001 5100 MT-ND2 ND ND ND ND ND ND ND ND ND ND
5101 5200 MT-ND2 ND ND ND ND ND ND ND ND ND ND
5201 5300 MT-ND2 ND ND ND ND ND ND ND ND ND ND
5301 5400 MT-ND2 ND ND ND ND ND ND ND ND ND ND
5401 5500 MT-ND2 ND ND ND ND ND ND ND ND ND ND
5501 5600 MT-ND2/MT-
TW/MT-TA
ND ND ND ND ND ND ND ND ND ND
5601 5700 MT-TA/MT-TN ND ND ND ND ND ND ND ND ND ND
5701 5800 MT-TN/MT-TC ND ND ND ND ND ND ND ND ND ND
5801 5900 MT-TC/MT-TY ND ND ND ND ND ND ND ND ND ND
5901 6000 MT-CO1 ND ND ND ND ND ND ND ND ND ND
6001 6100 MT-CO1 ND ND ND ND ND ND ND ND ND ND
6101 6200 MT-CO1 ND ND ND ND ND ND ND ND ND ND
6201 6300 MT-CO1 ND ND ND ND ND ND ND ND ND ND
6301 6400 MT-CO1 ND ND ND ND ND ND ND ND ND ND
6401 6500 MT-CO1 ND ND ND ND ND ND ND ND ND ND
6501 6600 MT-CO1 ND ND ND ND ND ND ND ND ND ND
6601 6700 MT-CO1 ND ND ND ND ND ND ND ND ND ND
6701 6800 MT-CO1 ND ND ND ND ND ND ND ND ND ND
6801 6900 MT-CO1 ND ND ND ND ND ND ND ND ND ND
6901 7000 MT-CO1 ND ND ND ND ND ND ND ND ND ND
7001 7100 MT-CO1 ND ND ND ND ND ND ND ND ND ND
7101 7200 MT-CO1 ND ND ND ND ND ND ND ND ND ND
7201 7300 MT-CO1 ND ND ND ND ND ND ND ND ND ND
7301 7400 MT-CO1 ND ND ND ND ND ND ND ND ND ND
7401 7500 MT-CO1/
MT-TS1
ND ND ND ND ND ND ND ND ND ND
7501 7600 MT-TS1/MT-
TD/MT-CO2
ND ND ND ND ND ND ND ND ND ND
7601 7700 MT-CO2 ND ND ND ND ND ND ND ND ND ND
7701 7800 MT-CO2 ND ND ND ND ND ND ND ND ND ND
7801 7900 MT-CO2 ND ND ND ND ND ND ND ND ND ND
7901 8000 MT-CO2 ND ND ND ND ND ND ND ND ND ND
8001 8100 MT-CO2 ND ND ND ND ND ND ND ND ND ND
8101 8200 MT-CO2 ND ND ND ND ND ND ND ND ND ND
8201 8300 MT-CO2/MT-TK ND ND ND ND ND ND ND ND ND ND
8301 8400 MT-TK/MT-ATP8 ND ND ND ND ND ND ND ND ND ND
8401 8500 MT-ATP8 ND ND ND ND ND ND ND ND ND ND
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Table 2 List of DMRs identified between five anatomically discreet cortical regions and cerebellum (Continued)
8501 8600 MT-ATP8/MT-ATP6 ND ND ND ND ND ND ND ND ND ND
8601 8700 MT-ATP6 ND ND ND ND ND ND ND ND ND ND
8701 8800 MT-ATP6 ND ND ND ND ND ND ND ND ND ND
8801 8900 MT-ATP6 ND ND ND ND ND ND ND ND ND ND
8901 9000 MT-ATP6 ND ND ND ND ND ND ND ND ND ND
9001 9100 MT-ATP6 ND ND ND ND ND ND ND ND ND ND
9101 9200 MT-ATP6 ND ND ND ND ND ND ND ND ND ND
9201 9300 MT-ATP6/MT-CO3 ND ND ND ND ND ND ND ND ND ND
9301 9400 MT-CO3 ND ND ND ND ND ND ND ND ND ND
9401 9500 MT-CO3 ND ND ND ND ND ND ND ND ND ND
9501 9600 MT-CO3 ND ND ND ND ND ND ND ND ND ND
9601 9700 MT-CO3 ND ND ND ND ND ND ND ND ND ND
9701 9800 MT-CO3 ND ND ND ND ND ND ND ND ND ND
9801 9900 MT-CO3 - - - - - - - - - -
9901 10000 MT-CO3/MT-TG - - - - - - - - - -
10001 10100 MT-TG/MT-ND3 - - - - - - - - - -
10101 10200 MT-ND3 - - - - - - - - - -
10201 10300 MT-ND3 4.68E−02 −662126 - - - - 3.14E−02 −591067 7.30E−03 −57012
10301 10400 MT-ND3/MT-
TR/MT-ND4L
3.61E−02 −132719 3.61E−02 −135759 4.02E−02 −115364 1.40E−02 −73063 3.36E−02 −105106
10401 10500 MT-ND4L - - 4.68E−02 −71246 - - - - - -
10501 10600 MT-ND4L - - - - - - - - - -
10601 10700 MT-ND4L ND ND ND ND ND ND ND ND ND ND
10701 10800 MT-ND4L/
MT-ND4
ND ND ND ND ND ND ND ND ND ND
10801 10900 MT-ND4 ND ND ND ND ND ND ND ND ND ND
10901 11000 MT-ND4 ND ND ND ND ND ND ND ND ND ND
11001 11100 MT-ND4 ND ND ND ND ND ND ND ND ND ND
11101 11200 MT-ND4 ND ND ND ND ND ND ND ND ND ND
11201 11300 MT-ND4 - - 1.94E−02 −68903 1.84E−02 −79625 4.71E−02 58742 - -
11301 11400 MT-ND4 - - 4.78E−02 −139847 - - - - - -
11401 11500 MT-ND4 ND ND ND ND ND ND ND ND ND ND
11501 11600 MT-ND4 ND ND ND ND ND ND ND ND ND ND
11601 11700 MT-ND4 ND ND ND ND ND ND ND ND ND ND
11701 11800 MT-ND4 ND ND ND ND ND ND ND ND ND ND
11801 11900 MT-ND4 ND ND ND ND ND ND ND ND ND ND
11901 12000 MT-ND4 ND ND ND ND ND ND ND ND ND ND
12001 12100 MT-ND4 ND ND ND ND ND ND ND ND ND ND
12101 12200 MT-ND4/MT-TH ND ND ND ND ND ND ND ND ND ND
12201 12300 MT-TS2/MT-TL2 ND ND ND ND ND ND ND ND ND ND
12301 12400 MT-TL2/MT-ND5 4.71E−02 1787 - −197592 - - - - - -
12401 12500 MT-ND5 - - - - - - - - - -
12501 12600 MT-ND5 - - - - - - - - - -
12601 12700 MT-ND5 - - - - - - - - - -
12701 12800 MT-ND5 2.05E−02 −5702 - - 4.58E−02 −388706 - - 4.36E−02 −394978
12801 12900 MT-ND5 2.26E−02 −89668 - - - - - - - -
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difference was maintained in all Brodmann area regions,
with three conserved regions of hypomethylation and
four conserved regions of hypermethylation, with re-
spect to the cerebellum. Furthermore, four of the seven
conserved regions were adjacent to each other within
the mitochondrial displacement loop (D-Loop) (16201–
16600 bp), a region associated with gene transcription
and DNA replication.
Table 2 List of DMRs identified between five anatomically discreet cortical regions and cerebellum (Continued)
12901 13000 MT-ND5 - - 3.10E−02 −130016 - - - - - -
13001 13100 MT-ND5 ND ND ND ND ND ND ND ND ND ND
13101 13200 MT-ND5 ND ND ND ND ND ND ND ND ND ND
13201 13300 MT-ND5 ND ND ND ND ND ND ND ND ND ND
13301 13400 MT-ND5 1.48E−02 −175917 - - 9.80E−03 −144949 3.40E−02 −133694 - -
13401 13500 MT-ND5 3.64E−02 −104010 - - 3.40E−02 −81264 - - - -
13501 13600 MT-ND5 - - - - - - - - - -
13601 13700 MT-ND5 - - - - - - - - - -
13701 13800 MT-ND5 1.31E−02 −422610 - - 1.20E−03 3714 - - - -
13801 13900 MT-ND5 - - 3.72E−02 708761 2.59E−02 123249 - - - -
13901 14000 MT-ND5 - - - - 2.17E−02 −75118 - - - -
14001 14100 MT-ND5 - - - - - - - - - -
14101 14200 MT-ND5/MT-ND6 - - - - - - - - 4.18E−02 −534766
14201 14300 MT-ND6 - - - - - - - - - -
14301 14400 MT-ND6 - - - - - - - - - -
14401 14500 MT-ND6 - - - - - - - - - -
14501 14600 MT-ND6 - - - - - - - - 4.86E−02 −82767
14601 14700 MT-ND6/MT-TE - - - - - - - - - -
14701 14800 MT-TE/MT-CYB - - - - - - - - - -
14801 14900 MT-CYB ND ND ND ND ND ND ND ND ND ND
14901 15000 MT-CYB ND ND ND ND ND ND ND ND ND ND
15001 15100 MT-CYB ND ND ND ND ND ND ND ND ND ND
15101 15200 MT-CYB - - - - - - - - - -
15201 15300 MT-CYB - - - - - - 1.20E−02 254183 - -
15301 15400 MT-CYB - - - - - - - - - -
15401 15500 MT-CYB 4.38E−02 10628 - - 2.10E−02 −554527 - - 3.28E−02 −554225
15501 15600 MT-CYB 3.73E−02 −671707 - - 1.23E−02 −685630 3.82E−02 9301 3.51E−02 −695515
15601 15700 MT-CYB - - - - 4.33E−02 −746270 - - - -
15701 15800 MT-CYB - - - - - - - - - -
15801 15900 MT-CYB/MT-TT - - - - - - - - - -
15901 16000 MT-TT/MT-TP - - - - - - - - - -
16001 16100 MT-TP - - - - - - - - - -
16101 16200 D-Loop - - 3.40E−03 3014 - - - - - -
16201 16300 D-Loop 4.64E−02 380407 2.50E−02 1117943 3.68E−02 296890 - - - -
16301 16400 D-Loop 3.65E−02 −941720 1.38E−02 −112453 2.73E−02 −177146 - - - -
16401 16500 D-Loop 4.29E−02 444051 2.20E−02 1151402 1.68E−02 313156 - - - -
16501 16600 D-Loop 3.71E−02 784572 2.10E−02 764994 2.46E−02 836662 - - - -
Shown is the location of the DMR within the mitochondrial genome (ChrM) (based on GENCODE), the gene(s) residing within the 100 bp window, and p value
from paired t tests between each of the five cortical regions: Brodmann areas 8, 9 and 10 (BA8, BA9, BA10), entorhinal cortex (ECX) and superior temporal gyrus
(STG) compared to the cerebellum (CER). Results are displayed in order of genomic position. RPKM and corresponding p values are shown for windows if p < 0.05.
Key: - denotes data not significant (p > 0.05); ND denotes not determined as the window was not included in analysis due to removal in NUMT pipeline. Results
shown in bold represent those found to be present across all prefrontal cortex areas (BA8, BA9, BA10)
Devall et al. Clinical Epigenetics  (2017) 9:47 Page 7 of 15
Fig. 3 (See legend on next page.)
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A number of differentially methylated regions in mtDNA
can be observed between the cortex and cerebellum
We were also interested to see whether total cortical tis-
sue was significantly different to matched cerebellum
samples. Given the paired nature of the different ana-
tomical regions of the cortex, we used a multilevel
mixed effects model to compare total cortex to cerebel-
lum (see the Methods section). This analysis revealed 48
nominally significant (p < 0.05) windows (Table 3; Fig. 4),
of which eight passed the Bonferroni correction (Table 3,
bold face). Interestingly, three of these eight were adja-
cent to each other, lying between 10301 and 10600 bp
and covering MT-ND3/MT-ND4L and MT-TR. We also
saw a Bonferroni significant difference in DNA methyla-
tion in the D-Loop, where we earlier noted DNA methy-
lation changes across all three Brodmann area regions.
MtDNA methylation patterns can distinguish between
tissue types
Although we have shown that mtDNA methylation
patterns are highly similar between distinct anatomical
regions of the human brain and blood, we were also
interested to identify whether mtDNA methylation
patterns could distinguish between these tissue types.
Through unsupervised hierarchical clustering, we showed
that average mtDNA methylation patterns can segregate
these tissues (Fig. 5a). Importantly, ncDNA methylation
profiles in the same samples have also been previously
shown to separate the cortex, cerebellum and blood [35].
Interestingly, when we performed unsupervised hierarch-
ical clustering on the individual samples, we found that, in
most cases, intra-individual differences across tissue types
are greater than inter-individual differences within each
tissue type, as the cortex, cerebellum and blood samples
clustered with their own tissue type, respectively (Fig. 5b).
Discussion
The availability of publicly available epigenomic data
provides a great resource for mitochondrial epigenetics,
a field that is relatively nascent and has yet to be thor-
oughly investigated in a range of complex diseases. Here,
we present evidence that mtDNA methylation patterns
across mtDNA are brain region specific. However, data
such as that presented here is confounded by a lack of
isolation of mtDNA prior to antibody enrichment and
sequencing. As such, the potential of including NUMTs
in datasets derived from data generated using total gen-
omic DNA could lead to misleading results. Here, we
controlled for regions of high sequence homology be-
tween the nuclear and mitochondrial genomes. However,
this approach is likely over-conservative and does lead
to the generation of a somewhat truncated consensus se-
quence. PCA of the mitochondrial epigenome after cor-
rections for nuclear homology was able to separate
individuals belonging to the three main tissue types, the
blood, cortex and cerebellum based on mtDNA methyla-
tion variation among tissue types. This tissue specificity
is further highlighted by the identification of eight DMRs
that pass the Bonferroni correction for multiple testing
between total cortex and cerebellum. MtDNA methyla-
tion has been shown to be cell line dependent in the
past. [31] Although overall DNA methylation levels were
low in all tissues, it is worth noting that the study was
performed on non bisulfite-treated DNA. As such, the
low percentage of mtDNA methylation is not a pitfall
due to a lack of a total bisulfite treatment efficiency.
One limitation of the current study is the unavailability
of publicly available MeDIP-seq datasets of matched cor-
tical and cerebellum tissue from other cohorts for valid-
ation purposes. Future work would aim to replicate our
findings in additional study cohorts and also to investi-
gate the relationship between mitochondrial DNA
methylation and gene expression.
Despite a number of nominally significant windows
being identified between each individual cortical re-
gion and the cerebellum, these did not pass the Bon-
ferroni correction, although it is likely this method is
too stringent. Nevertheless, the conservation of seven
nominally significant windows across each Brodmann
area is interesting to note. Four of these windows lie
adjacent to each other and correspond to the mito-
chondrial D-Loop, a region containing the only two
mitochondrial promoters which is typically associated
with gene transcription and DNA replication. How-
ever, one limitation of this study is owed to the use
of antibody-based enrichment, resulting in the an-
alysis being limited to a window-based approach.
Despite this, studies of the nuclear genome have
shown high correlation between window-based ap-
proaches and, more sensitive, single-site assays such
as the Illumina 450K beadarray [32]. However, given
the small size of the mitochondrial genome and that
(See figure on previous page.)
Fig. 3 DNA methylation differences are seen in the mitochondrial genome between brain regions and blood. Average raw RPKM values across the
mitochondrial genome for each individual cortical brain region alongside matched blood and cerebellum samples are shown in the top panel, with gene
positions downloaded from GENCODE shown in the middle panel. For each 100 bp window, paired t tests were performed to compare each cortical brain
region and the cerebellum, with -log10 (p) shown in the bottom panel. BLD blood, BA8 Brodmann area 8, BA9 Brodmann area 9, BA10 Brodmann area 10,
CER cerebellum, CTX cortex, ECX entorhinal cortex, RPKM reads per kilobase of transcript per million mapped reads, STG superior temporal gyrus. Red
dashed line denotes the Bonferroni significance, whilst blue dashed line denotes p< 0.05 in the lower panel
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Table 3 List of DMRs identified between total cortex and
cerebellum
Start (bp) Stop (bp) Gene(s) p value
1 100 D-Loop -
101 200 D-Loop -
201 300 D-Loop -
301 400 D-Loop -
401 500 D-Loop 7.99E−03
501 600 MT-TF 4.49E−03
601 700 MT-TF/MT-RNR1 1.16E−02
701 800 MT-RNR1 3.22E−03
801 900 MT-RNR1 1.91E−04
901 1000 MT-RNR1 ND
1001 1100 MT-RNR1 ND
1101 1200 MT-RNR1 ND
1201 1300 MT-RNR1 ND
1301 1400 MT-RNR1 ND
1401 1500 MT-RNR1 ND
1501 1600 MT-RNR1 ND
1601 1700 MT-RNR1/MT-TV/MT-RNR2 ND
1701 1800 MT-RNR2 ND
1801 1900 MT-RNR2 ND
1901 2000 MT-RNR2 ND
2001 2100 MT-RNR2 ND
2101 2200 MT-RNR2 ND
2201 2300 MT-RNR2 ND
2301 2400 MT-RNR2 8.10E−03
2401 2500 MT-RNR2 7.50E−03
2501 2600 MT-RNR2 5.14E−03
2601 2700 MT-RNR2 ND
2701 2800 MT-RNR2 ND
2801 2900 MT-RNR2 -
2901 3000 MT-RNR2 -
3001 3100 MT-RNR2 -
3101 3200 MT-RNR2 -
3201 3300 MT-RNR2/MT-TL 1.51E−03
3301 3400 MT-TL1/MT-ND1 -
3401 3500 MT-ND1 1.37E−02
3501 3600 MT-ND1 4.27E−03
3601 3700 MT-ND1 5.56E−03
3701 3800 MT-ND1 8.21E−03
3801 3900 MT-ND1 -
3901 4000 MT-ND1 -
4001 4100 MT-ND1 3.07E−06
4101 4200 MT-ND1 -
4201 4300 MT-ND1/MT-TI ND
Table 3 List of DMRs identified between total cortex and
cerebellum (Continued)
4301 4400 MT-TI/MT-TQ ND
4401 4500 MT-TM/MT-ND2 ND
4501 4600 MT-ND2 ND
4601 4700 MT-ND2 ND
4701 4800 MT-ND2 ND
4801 4900 MT-ND2 ND
4901 5000 MT-ND2 ND
5001 5100 MT-ND2 ND
5101 5200 MT-ND2 ND
5201 5300 MT-ND2 ND
5301 5400 MT-ND2 ND
5401 5500 MT-ND2 ND
5501 5600 MT-ND2/MT-TW/MT-TA ND
5601 5700 MT-TA/MT-TN ND
5701 5800 MT-TN/MT-TC ND
5801 5900 MT-TC/MT-TY ND
5901 6000 MT-CO1 ND
6001 6100 MT-CO1 ND
6101 6200 MT-CO1 ND
6201 6300 MT-CO1 ND
6301 6400 MT-CO1 ND
6401 6500 MT-CO1 ND
6501 6600 MT-CO1 ND
6601 6700 MT-CO1 ND
6701 6800 MT-CO1 ND
6801 6900 MT-CO1 ND
6901 7000 MT-CO1 ND
7001 7100 MT-CO1 ND
7101 7200 MT-CO1 ND
7201 7300 MT-CO1 ND
7301 7400 MT-CO1 ND
7401 7500 MT-CO1/MT-TS1 ND
7501 7600 MT-TS1/MT-TD/MT-CO2 ND
7601 7700 MT-CO2 ND
7701 7800 MT-CO2 ND
7801 7900 MT-CO2 ND
7901 8000 MT-CO2 ND
8001 8100 MT-CO2 ND
8101 8200 MT-CO2 ND
8201 8300 MT-CO2/MT-TK ND
8301 8400 MT-TK/MT-ATP8 ND
8401 8500 MT-ATP8 ND
8501 8600 MT-ATP8/MT-ATP6 ND
8601 8700 MT-ATP6 ND
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23 of the 37 genes present in the genome are below
100 bp in size, this window-based approach may not
be the most appropriate for future studies designed to
specifically assess mtDNA methylation as it can result
Table 3 List of DMRs identified between total cortex and
cerebellum (Continued)
8701 8800 MT-ATP6 ND
8801 8900 MT-ATP6 ND
8901 9000 MT-ATP6 ND
9001 9100 MT-ATP6 ND
9101 9200 MT-ATP6 ND
9201 9300 MT-ATP6/MT-CO3 ND
9301 9400 MT-CO3 ND
9401 9500 MT-CO3 ND
9501 9600 MT-CO3 ND
9601 9700 MT-CO3 ND
9701 9800 MT-CO3 ND
9801 9900 MT-CO3 -
9901 10000 MT-CO3/MT-TG -
10001 10100 MT-TG/MT-ND3 1.81E−02
10101 10200 MT-ND3 1.39E−02
10201 10300 MT-ND3 3.53E−04
10301 10400 MT-ND3/MT-TR/MT-ND4L 1.19E−05
10401 10500 MT-ND4L 2.61E−04
10501 10600 MT-ND4L 9.05E−04
10601 10700 MT-ND4L ND
10701 10800 MT-ND4L/MT-ND4 ND
10801 10900 MT-ND4 ND
10901 11000 MT-ND4 ND
11001 11100 MT-ND4 ND
11101 11200 MT-ND4 ND
11201 11300 MT-ND4 8.86E−05
11301 11400 MT-ND4 1.65E−03
11401 11500 MT-ND4 ND
11501 11600 MT-ND4 ND
11601 11700 MT-ND4 ND
11701 11800 MT-ND4 ND
11801 11900 MT-ND4 ND
11901 12000 MT-ND4 ND
12001 12100 MT-ND4 ND
12101 12200 MT-ND4/MT-TH ND
12201 12300 MT-TS2/MT-TL2 ND
12301 12400 MT-TL2/MT-ND5 -
12401 12500 MT-ND5 -
12501 12600 MT-ND5 -
12601 12700 MT-ND5 -
12701 12800 MT-ND5 1.81E−03
12801 12900 MT-ND5 1.05E−02
12901 13000 MT-ND5 8.23E−03
13001 13100 MT-ND5 ND
Table 3 List of DMRs identified between total cortex and
cerebellum (Continued)
13101 13200 MT-ND5 ND
13201 13300 MT-ND5 ND
13301 13400 MT-ND5 1.44E−03
13401 13500 MT-ND5 9.13E−04
13501 13600 MT-ND5 1.61E−02
13601 13700 MT-ND5 3.89E−02
13701 13800 MT-ND5 2.77E−04
13801 13900 MT-ND5 2.80E−03
13901 14000 MT-ND5 1.88E−02
14001 14100 MT-ND5 9.31E−03
14101 14200 MT-ND5/MT-ND6 -
14201 14300 MT-ND6 -
14301 14400 MT-ND6 1.04E−02
14401 14500 MT-ND6 1.99E−02
14501 14600 MT-ND6 2.26E−02
14601 14700 MT-ND6/MT-TE 3.82E−03
14701 14800 MT-TE/MT-CYB 1.92E−02
14801 14900 MT-CYB ND
14901 15000 MT-CYB ND
15001 15100 MT-CYB ND
15101 15200 MT-CYB 3.30E−02
15201 15300 MT-CYB -
15301 15400 MT-CYB -
15401 15500 MT-CYB 8.52E−04
15501 15600 MT-CYB 7.43E−04
15601 15700 MT-CYB 1.16E−02
15701 15800 MT-CYB 2.24E−02
15801 15900 MT-CYB/MT-TT -
15901 16000 MT-TT/MT-TP -
16001 16100 MT-TP -
16101 16200 D-Loop 2.23E−03
16201 16300 D-Loop 5.02E−04
16301 16400 D-Loop 1.84E−03
16401 16500 D-Loop 1.12E−03
16501 16600 D-Loop 2.20E−03
Shown is the location of the DMR within ChrM (based on GENCODE), the
gene(s) residing within the 100 bp window, and p value from a multilevel
mixed effects model. Results are displayed in order of genomic position. RPKM
and corresponding p values are shown for windows if p < 0.05. Key: - denotes
data not significant (p > 0.05); ND denotes not determined as the window was
not included in analysis due to removal in NUMT pipeline; bold denotes
windows that reached our Bonferroni significant threshold of p < 7.04E−04
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Fig. 4 (See legend on next page.)
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in a window intersecting two genes in the polycis-
tronic transcript.
Conclusions
This method provides a conservative approach to deter-
mine mtDNA methylation across the genome for data
previously generated using next-generation sequencing
approaches such as MeDIP-seq. Its conservative nature
reduces the risk of the inclusion of NUMTs in the final
analysis of whole genome data but may also lead to the
inclusion of false negatives as well as potential gaps in
the reference sequence. As such, it is best suited to ana-
lyzing previously generated whole genome data and is
not a replacement for the isolation of mitochondrial DNA
[36] prior to targeted methylation studies, which would be
the optimal approach for investigating mitochondrial epi-
genomics. However, our method has allowed the identifi-
cation of novel brain-region-specific DMRs in a previously
generated publicly available dataset. Furthermore, the
identification of brain region-specific mtDNA methylation
patterns across the mitochondrial epigenome suggests the
importance of a focussed, tissue-specific study design
when investigating mtDNA methylation. As previously
discussed, one caveat when utilizing MeDIP-seq data is
the segregation of data into neighbouring windows, mean-
ing that determining the exact corresponding gene of a
DMR is difficult and, as such, future studies should aim to
sequence the mitochondrial DNA methylome at single-
base resolution to address this.
Methods
Data collection
We utilized publicly available MeDIP-seq data from
Davies et al. [35]. In brief, this data was generated using
5 μg fragmented gDNA, which, following end repair
<A> base addition and adaptor ligation, was immuno-
precipitated using an anti-5-mC antibody (Diagenode,
Liège, Belgium). MeDIP DNA was purified and then
amplified using adaptor-mediated PCR, with DNA frag-
ments between 220 and 320 bp subjected to highly par-
allel 50 bp paired-end sequencing on the Illumina Hi-
Seq platform. The paired-end, raw fasta files were pro-
vided by the authors and quality checked using FastQC.
Sample information is provided in Table 1.
Fig. 5 MtDNA methylation patterns can distinguish between tissue
types. a Average RPKM values for each cortical brain region,
cerebellum and blood samples were clustered based upon the
Euclidean distance, identifying two major clusters; the cortex and
blood-cerebellum. b When clustering RPKM values in the individual
samples from the cortex, cerebellum and blood, we observed that
individual cortex samples clustered together, whilst cerebellum and
blood samples formed separate clusters. This highlights that tissue-
specific differences between the cortex, cerebellum and blood are
greater than intra-individual variability within a tissue. BLD blood, BA8
Brodmann area 8, BA9 Brodmann area 9, BA10 Brodmann area 10, CER
cerebellum, CTX cortex, ECX entorhinal cortex, RPKM reads per kilobase
of transcript per million mapped reads, STG superior temporal gyrus
(See figure on previous page.)
Fig. 4 DNA methylation differences are seen in the mitochondrial genome between the cerebellum and cortex. RPKM values in the total cortex
and cerebellum across the mitochondrial genome are shown in the top panel, with gene positions downloaded from GENCODE shown in the
middle panel. For each 100 bp window, paired t tests were performed to compare the cortex to the cerebellum, with -log10 (p) shown in the
bottom panel. BLD blood, BA8 Brodmann area 8, BA9 Brodmann area 9, BA10 Brodmann area 10, CER cerebellum, CTX cortex, ECX entorhinal
cortex, RPKM reads per kilobase of transcript per million mapped reads, STG superior temporal gyrus. Red dashed line denotes the Bonferroni
significance, whilst blue dashed line denotes p < 0.05 in the lower panel
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Quality control and NUMT exclusion
Fasta files were subjected to adaptor and Phred score
(q < 20) trimming. In an attempt to remove any potential
contamination of possible NUMTs, multiple alignments
to the reference genome were undertaken. Paired fasta
files were aligned to GRCH37 using BWA. Unique and
mapped reads aligning to the mitochondria were then
re-mapped to a custom GRCH37 reference without the
mitochondrial chromosome. Reads not mapping to the
custom reference were then taken forward and realigned
to the full GRCH37 reference to eliminate the possibility
of homologous regions mapping falsely to the mitochon-
drial genome (Fig. 1). All alignments were carried out
using BWA mem and default settings. Reads per kilo-
base of transcript per million mapped reads (RPKM)
values for each sample were calculated using the MEDIPS
package [37]. Methylation was averaged across 100 bp
non-overlapping windows (default parameter setting in
MEDIPS), and only windows with read counts >10 were
considered for analysis. Due to the non-normal distribu-
tion of all cohorts, RPKM values were log2 transformed
before statistical analysis.
Statistical analyses
All analyses were performed in the R statistical environ-
ment version 3.2.1 [38]. For all analyses, a nominally sig-
nificant threshold of p < 0.05 and a Bonferroni significant
threshold of p < 7.04E−04 were used. Given the matched
sample nature of this cohort, two-tailed, paired t tests
were performed at each window along the mitochondrial
genome to identify DMRs between the individual cortical
regions and cerebellum. To compare the total cortex to
cerebellum, we performed a multilevel mixed effects
model in the Lme4 package in R [39], using the brain
region as the random effect and individual as the fixed
effect. To assess the similarity of the brain regions, we
used the R function “hclust” to cluster average RPKM
values for the brain regions using the Euclidean distance.
We used the R function “corrgram” within the corrgram
package [40] to order samples based upon the similarity of
their principal components.
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